All Stories

  1. Integrating Advanced Metabolomics and Machine Learning for Anti-Doping in Human Athletes
  2. New long‐standing metabolites of 17α‐methyltestosterone are detected in HepG2 cell in vitro metabolic model and in human urine
  3. Untargeted Metabolomics Identifies a Novel Panel of Markers for Autologous Blood Transfusion
  4. Integrating Whole Blood Transcriptomic Collection Procedures Into the Current Anti-Doping Testing System, Including Long-Term Storage and Re-Testing of Anti-Doping Samples
  5. Olympic anti-doping laboratory: the analytical technological road from 2016 Rio De Janeiro to 2021 Tokyo
  6. Red blood cell derived extracellular vesicles during the process of autologous blood doping
  7. The use of RNA‐based 5'‐aminolevulinate synthase 2 biomarkers in dried blood spots to detect recombinant human erythropoietin microdoses
  8. Ultra‐fast retroactive processing by MetAlign of liquid chromatography/high‐resolution full‐scan Orbitrap mass spectrometry data in WADA Human Urine Sample Monitoring Program
  9. Horseradish‐peroxidase‐conjugated anti‐erythropoietin antibodies for direct recombinant human erythropoietin detection: Proof of concept
  10. Biosafety Level 2 cabinet UV‐C light exposure of sports antidoping human urine samples does not affect the stability of selected prohibited substances
  11. Assessment of Serum Cytokines and Oxidative Stress Markers in Elite Athletes Reveals Unique Profiles Associated With Different Sport Disciplines
  12. Alternative markers for Methylnortestosterone misuse in human urine
  13. Author Correction: Metabolic GWAS of elite athletes reveals novel genetically-influenced metabolites associated with athletic performance
  14. Hyperhydration using different hydration agents does not affect the haematological markers of the athlete biological passport in euhydrated volunteers
  15. Genome-Wide Association Study Reveals a Novel Association Between MYBPC3 Gene Polymorphism, Endurance Athlete Status, Aerobic Capacity and Steroid Metabolism
  16. Metabolomics and doping analysis: promises and pitfalls
  17. A novel mixed living high training low intervention and the hematological module of the athlete biological passport
  18. Detecting – the 2004 Athens Olympic Games
  19. Metabolic GWAS of elite athletes reveals novel genetically-influenced metabolites associated with athletic performance
  20. Population reference ranges of urinary endogenous sulfate steroids concentrations and ratios as complement to the steroid profile in sports antidoping
  21. Genome-wide association study reveals novel genetic markers associated with endurance athlete status
  22. Ultra‐fast retroactive processing of liquid chromatography high‐resolution full‐scan Orbitrap mass spectrometry data in anti‐doping screening of human urine
  23. Effect of hyperhydration on the pharmacokinetics and detection of orally administered budesonide in doping control analysis
  24. Hyperhydration Effect on Pharmacokinetic Parameters and Detection Sensitivity of Recombinant Human Erythropoietin in Urine and Serum Doping Control Analysis of Males
  25. Metabolic profiling of elite athletes with different cardiovascular demand
  26. Hyperhydration-Induced Decrease in Urinary Luteinizing Hormone Concentrations of Male Athletes in Doping Control Analysis
  27. Whole Blood Storage in CPDA1 Blood Bags Alters Erythrocyte Membrane Proteome
  28. Comparison of gas chromatography/quadrupole time-of-flight and quadrupole Orbitrap mass spectrometry in anti-doping analysis: I. Detection of anabolic-androgenic steroids
  29. The effect of athletes` hyperhydration on the urinary ‘steroid profile’ markers in doping control analysis
  30. High resolution full scan liquid chromatography mass spectrometry comprehensive screening in sports antidoping urine analysis
  31. A pilot study comparing the metabolic profiles of elite-level athletes from different sporting disciplines
  32. Metabolomics profiling of xenobiotics in elite athletes: relevance to supplement consumption
  33. Gas chromatographic quadrupole time-of-flight full scan high resolution mass spectrometric screening of human urine in antidoping analysis
  34. Analysis of RBC-microparticles in stored whole blood bags - a promising marker to detect blood doping in sports?
  35. Analytical progresses of the World Anti-Doping Agency Olympic laboratories: a 2016 update from London to Rio
  36. Doping control container for urine stabilization: a pilot study
  37. Athlome Project Consortium: a concerted effort to discover genomic and other “omic” markers of athletic performance
  38. The effect of fasting during Ramadan on parameters of the haematological and steroidal modules of the athletes biological passport - a pilot study
  39. Markers of mesterolone abuse in sulfate fraction for doping control in human urine
  40. Comparison of sulfo-conjugated and gluco-conjugated urinary metabolites for detection of methenolone misuse in doping control by LC-HRMS, GC-MS and GC-HRMS
  41. Gas chromatographic–mass spectrometric quantitation of busulfan in human plasma for therapeutic drug monitoring: A new on-line derivatization procedure for the conversion of busulfan to 1,4-diiodobutane
  42. Advances in the detection of designer steroids in anti-doping
  43. A generic screening methodology for horse doping control by LC–TOF-MS, GC–HRMS and GC–MS
  44. A Synopsis of the Adverse Analytical and Atypical Findings Between 2005 and 2011 from the Doping Control Laboratory of Athens in Greece
  45. Sports doping: Emerging designer and therapeutic β2-agonists
  46. Chemical derivatization to enhance ionization of anabolic steroids in LC-MS for doping-control analysis
  47. Comparison of multiple linear regression, partial least squares and artificial neural networks for prediction of gas chromatographic relative retention times of trimethylsilylated anabolic androgenic steroids
  48. Evolving concepts and techniques for anti-doping
  49. Analytical progresses of the International Olympic Committee and World Anti-Doping Agency Olympic laboratories
  50. Examination of the kinetic isotopic effect to the acetylation derivatization for the gas chromatographic-combustion-isotope ratio mass spectrometric doping control analysis of endogenous steroids
  51. Two-step derivatization procedures for the ionization enhancement of anabolic steroids in LC–ESI-MS for doping control analysis
  52. External calibration in Gas Chromatography–Combustion–Isotope Ratio Mass Spectrometry measurements of endogenous androgenic anabolic steroids in sports doping control
  53. Stabilization of human urine doping control samples: a current opinion
  54. Screening in veterinary drug analysis and sports doping control based on full-scan, accurate-mass spectrometry
  55. Stabilization of human urine doping control samples: IV. Human chorionic gonadotropin
  56. Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry
  57. Stabilization of human urine doping control samples: III. Recombinant human erythropoietin
  58. Generic sample preparation combined with high-resolution liquid chromatography–time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories
  59. Estimating measurement uncertainty in quantitative methods not based on chromatography for doping control purposes
  60. Gas chromatographic quantitative structure–retention relationships of trimethylsilylated anabolic androgenic steroids by multiple linear regression and partial least squares
  61. Two-step silylation procedure for the unified analysis of 190 doping control substances in human urine samples by GC–MS
  62. Direct injection horse urine analysis for the quantification and identification of threshold substances for doping control. III. Determination of salicylic acid by liquid chromatography/quadrupole time-of-flight mass spectrometry
  63. Statistical analysis of fragmentation patterns of electron ionization mass spectra of enolized-trimethylsilylated anabolic androgenic steroids
  64. Direct injection horse-urine analysis for the quantification and confirmation of threshold substances for doping control. IV. Determination of 3-methoxytyramine by hydrophilic interaction liquid chromatography/quadrupole time-of-flight mass spectrometry
  65. Searching for in silico predicted metabolites and designer modifications of (cortico)steroids in urine by high-resolution liquid chromatography/time-of-flight mass spectrometry
  66. Stabilization of human urine doping control samples: II. Microbial degradation of steroids
  67. Stabilization of human urine doping control samples
  68. Schemes of metabolic patterns of anabolic androgenic steroids for the estimation of metabolites of designer steroids in human urine
  69. Direct injection liquid chromatography/electrospray ionization mass spectrometric horse urine analysis for the quantification and confirmation of threshold substances for doping control. II. Determination of theobromine
  70. Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities
  71. Direct injection LC/ESI-MS horse urine analysis for the quantification and identification of threshold substances for doping control. I. Determination of hydrocortisone
  72. ISO/IEC 17025 Sysmex R-500 Hematology Reticulocyte Analyzer Validation
  73. Multi-detection of corticosteroids in sports doping and veterinary control using high-resolution liquid chromatography/time-of-flight mass spectrometry
  74. Electrophoretic, size-exclusion high-performance liquid chromatography and liquid chromatography–electrospray ionization ion trap mass spectrometric detection of hemoglobin-based oxygen carriers
  75. Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids
  76. Organization of the doping control laboratory in the Athens 2004 Olympic Games: A case study
  77. Doping control analysis in human urine by liquid chromatography–electrospray ionization ion trap mass spectrometry for the Olympic Games Athens 2004: Determination of corticosteroids and quantification of ephedrines, salbutamol and morphine
  78. An overview of the doping control analysis during the Olympic Games of 2004 in Athens, Greece
  79. Metabolism of isometheptene in human urine and analysis by gas chromatography–mass spectrometry in doping control
  80. Another designer steroid: discovery, synthesis, and detection of ?madol? in urine
  81. Quantitative structure–retention relationship study of α-, β1-, and β2-agonists using multiple linear regression and partial least-squares procedures
  82. Determination of xylazine and its metabolites by GC–MS in equine urine for doping analysis
  83. Gas Chromatographic ? Mass Spectrometric Cardiotonic Glycosides Detection in Equine Urine Doping Analysis
  84. Elimination profiles of flurbiprofen and its metabolites in equine urine for doping analysis
  85. Determination of ephedrines in urine by gas chromatography–mass spectrometry
  86. Study of excretion of ecdysterone in human urine
  87. Excretion study of the β2-agonist reproterol in human urine
  88. Doping control analysis: the 6th World Championships of Athletics, Athens, Greece
  89. An expert system for the interpretation of pyrolysis mass spectra of condensation polymers
  90. Quantitative structure-retention relationships in doping control
  91. Principal component analysis for resolving coeluting substances in gas chromatography-mass spectrometry doping control analysis
  92. A method for the interpretation of pyrolysis-mass spectra of polyesters
  93. HEPHESTUS: An expert system in PROLOG for the interpretation of the pyrolysis-mass spectra of polyesters, polyethers and polyureas using the certainty factor model
  94. Assessment of the performance of various search systems for mass spectra files of steroids
  95. HEPHESTUS: An expert system in PROLOG for the interpretation of pyrolysis mass spectra of polyesters, polyethers and polyureas
  96. A method for the interpretation of pyrolysis-mass spectra of polyamides
  97. Prediction of gas chromatographic relative retention times of anabolic steroids
  98. Prediction of gas chromatographic relative retention times of stimulants and narcotics
  99. The interpretation of pyrolysis mass spectra of polymers using a “hybrid” software system based on library searching with heuristics